€6.5m · Other round · Healthtech · Berlin, Germany
Berlin-based AssistMe has raised €6.5m in funding to expand alea, its connected care platform for professional nursing. CRB Health Tech and Vorwerk Ventures led the round, with SUM Ventures and existing investors Brandenburg Kapital, Conle Family Office, Next Big Thing and IBB Capital participating, according to the company announcement. The capital will support European sales, further product development and preparation for a planned US market entry in 2027.
AssistMe founders Julio Brandl (CEO) and Alexander Meiritz (CFO and COO). Image: AssistMe.
Care data has to arrive in the workflow
alea combines software with connected hardware to show care teams information that is difficult to collect consistently during a busy shift. AssistMe says the platform can indicate whether an incontinence product needs changing, how a resident is positioned, when they were last repositioned and whether a fall may have occurred. Relevant events can then flow into care documentation rather than remaining in a separate dashboard.
That workflow matters commercially because the product is not only a sensor sale. A care provider has to fit the hardware into rooms and routines, train staff to trust the alerts, and connect the resulting information to documentation and task coordination. When those pieces work together, alea can become part of daily operations; when they do not, more data risks creating another system for staff to check.
AssistMe says alea is already used by large and small providers, including facilities operated by Johanniter, AWO, Führer Group and Argentum Group. The company also reports that monthly recurring revenue increased more than sixfold over the past six months. Those are company-reported figures, but they indicate that the round follows operating deployments rather than funding a first pilot.
International growth tests repeatable deployment
The platform is in use in eight European countries, and AssistMe plans to deepen that footprint while preparing a US launch. Expansion will test how repeatably the company can install hardware, configure workflows and demonstrate value across providers with different care processes, documentation systems and purchasing structures.
AssistMe is also extending alea from residential long-term care into home care. That broadens the addressable setting, but it changes the operating context: data and alerts must support distributed carers and households rather than staff working inside one facility. The same product architecture may travel, yet deployment, support and accountability will need to travel with it.
The €6.5m therefore finances two connected tests. AssistMe must turn strong reported growth into repeatable provider adoption across markets, while showing that its care-data layer remains useful as it moves from institutions into homes. Product development and sales expansion reinforce each other only if implementations become easier without weakening the workflow fit that made the platform valuable in the first place.
